two non drug eluting stent implantation for bifurcation lesion of coronary artery相关文献:
Two-Year Outcomes and Predictors of Target Lesion Revascularization for Non-Left Main Coronary Bifurcation Lesions Following Two-Stent Strategy With 2nd-Generation Drug-Eluting Stents.
Ohya M, Morimoto T, Kubo S, Habara S, Kuwayama A, Miura K, Shimada T, Amano H, Otsuru S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K.
Circ J. 2018 Feb 23;82(3):798-806. doi: 10.1253/circj.CJ-17-1092. Epub 2017 Dec 19.
PMID:29269613
Stenting strategy for coronary artery bifurcation with drug-eluting stents: a meta-analysis of nine randomised trials and systematic review.
Gao XF, Zhang YJ, Tian NL, Wu W, Li MH, Bourantas CV, Jiang XM, Wang ZM, Li B, Mao WX, Zhang JJ, Chen SL.
Comparing two-stent strategies for bifurcation coronary lesions: which vessel should be stented first, the main vessel or the side branch?
Shin DH, Park KW, Koo BK, Oh IY, Seo JB, Gwon HC, Jeong MH, Seong IW, Rha SW, Yang JY, Park SJ, Yoon JH, Han KR, Park JS, Hur SH, Tahk SJ, Kim HS.
J Korean Med Sci. 2011 Aug;26(8):1031-40. doi: 10.3346/jkms.2011.26.8.1031. Epub 2011 Jul 27.
PMID:21860553
Long-term clinical outcomes of the one-stent technique versus the two-stent technique for non-left main true coronary bifurcation disease in the era of drug-eluting stents.
Koh YS, Kim PJ, Chang K, Park HJ, Jeong MH, Kim HS, Jang Y, Gwon HC, Park SJ, Seung KB.
Three-year outcome of sirolimus-eluting stent implantation in coronary bifurcation lesions: the provisional side branch stenting approach versus the elective two-stent approach.